vs

Side-by-side financial comparison of Exodus Movement, Inc. (EXOD) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $29.4M, roughly 2.0× Exodus Movement, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -34.4%). Exodus Movement, Inc. produced more free cash flow last quarter ($-25.8M vs $-167.0M).

Exodus is a cryptocurrency wallet available on desktop and mobile platforms. It was founded in 2015 by JP Richardson and Daniel Castagnoli. Exodus wallet supports digital assets including Bitcoin, Ethereum, and Solana. It is available on Windows, macOS, Linux, iOS, Android, and as a browser extension.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

EXOD vs PHAT — Head-to-Head

Bigger by revenue
PHAT
PHAT
2.0× larger
PHAT
$57.6M
$29.4M
EXOD
Growing faster (revenue YoY)
PHAT
PHAT
+128.5% gap
PHAT
94.1%
-34.4%
EXOD
More free cash flow
EXOD
EXOD
$141.2M more FCF
EXOD
$-25.8M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EXOD
EXOD
PHAT
PHAT
Revenue
$29.4M
$57.6M
Net Profit
$-53.2M
Gross Margin
86.7%
Operating Margin
-226.9%
Net Margin
-181.0%
Revenue YoY
-34.4%
94.1%
Net Profit YoY
-179.5%
71.6%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXOD
EXOD
PHAT
PHAT
Q4 25
$29.4M
$57.6M
Q3 25
$30.3M
$49.5M
Q2 25
$25.8M
$39.5M
Q1 25
$36.0M
$28.5M
Q4 24
$44.8M
$29.7M
Q3 24
$20.1M
$16.4M
Q2 24
$22.3M
$7.3M
Q1 24
$29.1M
Net Profit
EXOD
EXOD
PHAT
PHAT
Q4 25
$-53.2M
Q3 25
$17.0M
$-30.0M
Q2 25
$37.7M
$-75.8M
Q1 25
$-12.9M
$-94.3M
Q4 24
$66.9M
Q3 24
$843.0K
$-85.6M
Q2 24
$-9.6M
$-91.4M
Q1 24
$54.8M
Gross Margin
EXOD
EXOD
PHAT
PHAT
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
43.7%
85.6%
Q2 24
51.7%
81.2%
Q1 24
63.2%
Operating Margin
EXOD
EXOD
PHAT
PHAT
Q4 25
-226.9%
Q3 25
66.9%
-30.8%
Q2 25
-151.7%
Q1 25
-60.4%
-276.5%
Q4 24
Q3 24
-0.3%
-433.0%
Q2 24
-66.1%
-1055.4%
Q1 24
Net Margin
EXOD
EXOD
PHAT
PHAT
Q4 25
-181.0%
Q3 25
56.2%
-60.5%
Q2 25
145.8%
-191.9%
Q1 25
-35.8%
-330.7%
Q4 24
149.4%
Q3 24
4.2%
-523.3%
Q2 24
-43.1%
-1248.6%
Q1 24
188.5%
EPS (diluted)
EXOD
EXOD
PHAT
PHAT
Q4 25
Q3 25
$-0.41
Q2 25
$-1.05
Q1 25
$-1.31
Q4 24
Q3 24
$-1.32
Q2 24
$-1.56
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXOD
EXOD
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$4.9M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$247.4M
$-438.2M
Total Assets
$266.8M
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXOD
EXOD
PHAT
PHAT
Q4 25
$4.9M
$130.0M
Q3 25
$50.5M
$135.2M
Q2 25
$52.9M
$149.6M
Q1 25
$59.8M
$212.3M
Q4 24
$37.9M
$297.3M
Q3 24
$26.5M
$334.7M
Q2 24
$27.8M
$276.2M
Q1 24
$21.0M
Total Debt
EXOD
EXOD
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
EXOD
EXOD
PHAT
PHAT
Q4 25
$247.4M
$-438.2M
Q3 25
$296.7M
$-422.5M
Q2 25
$277.1M
$-405.8M
Q1 25
$241.5M
$-338.4M
Q4 24
$257.5M
$-253.6M
Q3 24
$191.2M
$-187.1M
Q2 24
$190.8M
$-233.8M
Q1 24
$199.1M
Total Assets
EXOD
EXOD
PHAT
PHAT
Q4 25
$266.8M
$259.1M
Q3 25
$338.5M
$240.3M
Q2 25
$313.7M
$250.2M
Q1 25
$263.2M
$294.2M
Q4 24
$288.0M
$378.3M
Q3 24
$211.6M
$387.0M
Q2 24
$211.6M
$319.4M
Q1 24
$225.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXOD
EXOD
PHAT
PHAT
Operating Cash FlowLast quarter
$-25.6M
$-166.8M
Free Cash FlowOCF − Capex
$-25.8M
$-167.0M
FCF MarginFCF / Revenue
-87.9%
-290.0%
Capex IntensityCapex / Revenue
0.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.3M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXOD
EXOD
PHAT
PHAT
Q4 25
$-25.6M
$-166.8M
Q3 25
$-4.8M
$-14.1M
Q2 25
$-5.3M
$-62.7M
Q1 25
$-6.2M
$-84.9M
Q4 24
$-12.0M
$-266.8M
Q3 24
$-4.9M
$-63.6M
Q2 24
$-2.4M
$-70.7M
Q1 24
$450.0K
Free Cash Flow
EXOD
EXOD
PHAT
PHAT
Q4 25
$-25.8M
$-167.0M
Q3 25
$-4.8M
$-14.1M
Q2 25
$-5.4M
$-62.8M
Q1 25
$-6.2M
$-84.9M
Q4 24
$-12.3M
$-266.9M
Q3 24
$-4.9M
$-63.6M
Q2 24
$-2.4M
$-70.8M
Q1 24
$300.0K
FCF Margin
EXOD
EXOD
PHAT
PHAT
Q4 25
-87.9%
-290.0%
Q3 25
-16.0%
-28.6%
Q2 25
-20.7%
-159.0%
Q1 25
-17.3%
-297.9%
Q4 24
-27.5%
-899.8%
Q3 24
-24.5%
-389.0%
Q2 24
-10.8%
-966.2%
Q1 24
1.0%
Capex Intensity
EXOD
EXOD
PHAT
PHAT
Q4 25
0.9%
0.4%
Q3 25
0.1%
0.1%
Q2 25
0.4%
0.2%
Q1 25
0.1%
0.1%
Q4 24
0.6%
0.5%
Q3 24
0.2%
0.3%
Q2 24
0.2%
0.6%
Q1 24
0.5%
Cash Conversion
EXOD
EXOD
PHAT
PHAT
Q4 25
Q3 25
-0.28×
Q2 25
-0.14×
Q1 25
Q4 24
-0.18×
Q3 24
-5.80×
Q2 24
Q1 24
0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXOD
EXOD

Exchange Aggregation$26.6M90%
Other$2.8M10%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons